Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia

American Journal of Cardiology

Volumn 85, Issue 9, 2000, Pages 1100-1105

  Goldberg, Anne ^a   Alagona Jr , Peter ^b   Capuzzi, David M ^c   Guyton, John ^d   Morgan, John M ^c   Rodgers, John ^e   Sachson, Richard ^f   Samuel, Paul ^g  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b St Joseph's Heart Institute   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e ALBANY MEDICAL COLLEGE   (United States)

^f Research Institute of Dallas   (United States)

^g LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; PLACEBO; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SUSTAINED RELEASE FORMULATION;

ADULT; AGED; APOLIPOPROTEINS B; CHOLESTEROL, LDL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; NIACIN; TREATMENT OUTCOME;

EID: 0034191863     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)00703-7     Document Type: Article

References (17)

1. Clark A.B., Holt J.M. Identifying and managing patients with hyperlipidemia. Am J Managed Care. 3:1997;1211-1219.
2. McKenney J.M., Proctor J.D., Harris S., Chinchili V.M. A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients. JAMA. 271:1994;672-677.
3. Luria M.H. Effect of low-dose niacin on high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol ratio. Arch Intern Med. 148:1988;2493-2495.
4. Superko H.R., Krauss R.M. Differential effects of nicotinic acid in subjects with different LDL subclass patterns. Atherosclerosis. 95:1992;69-76.
5. Kannel W.B. Range of serum cholesterol values in the population developing coronary artery disease. Am J Cardiol. 76:1995;69C-77C.
6. Report of the National Cholesterol Education Program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med. 148:1988;36-69.
7. Knopp R.H., Ginsberg J., Albers J.J., Hoff C., Ogilvie J.T., Warnick R., Burrows E., Retzlaff B., Poole M. Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects clues to mechanism of action of niacin . Metabolism. 34:1985;642-650.
8. Gray D.R., Morgan T., Chretien S.D., Kashyap M.L. Efficacy and safety of controlled-release niacin in dyslipoproteinemic veterans. Ann Intern Med. 121:1994;252-258.
9. Rader J.I., Calvert R.J., Hathcock J.N. Hepatic toxicity of unmodified and time-release preparations of niacin. Am J Med. 92:1992;77-81.
10. Knopp R.H. Niacin and hepatic failure. [Letter] Ann Intern Med. 111:1989;769.
11. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA. 269:1993;3015-3023.
12. Warnick G.R., Benderson J., Albers J.J. Dextran sulfate-Mg+2 precipitation for quantification of high-density lipoprotein cholesterol. Clin Chem. 28:1982;1379-1388.
13. Manual of laboratory operations. In: Hainline A, Karon J, Lippel K, eds. Lipid Research Clinics Program, Lipid and Lipoprotein analysis. 2nd ed. Bethesda, MD: U.S. Department of Health and Human Services, 1982.
14. Morgan J.M., Capuzzi D.M., Guyton J.R., Centor R.M., Goldberg R., Robbins D.C., DiPette D., Jenkins S., Marcovina S. Treatment effect of Niaspan, a controlled-release niacin, in patients with hypercholesterolemia a placebo-controlled trial . J Cardiovasc Pharmacol Ther. 1:1996;195-202.
15. Genest J. Jr, McNamara J.R., Ordovas M.J.M., Jenner J.L., Silberman S.R., Anderson K.M., Wilson P.W.F., Salem D.N., Schaeffer E.J. Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. J Am Coll Cardiol. 19:1992;792-802.
16. Mosher L.R. Nicotinic acid side effects and toxicity a review . Am J Psychiatry. 126:1970;1290-1296.
17. Belle M., Halpern M. Oral nicotinic acid for hyperlipidemia with emphasis on side effects. Am J Cardiol. 2:1958;449-452.